Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
no sampling
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject fulfils criteria for Rheumatoid Arthritis (RA) according to ACR or EULAR criteria.
Subjects who are planned to start treatment with ADA, ETA, CER or IFX
Subjects taking a minimum weekly dose of 7.5 mg of methotrexate
You may not be if
Patients with compliance problems
Patients who have difficulties in reading and understanding local language
Patients with Juvenile Idiopathic Arthritis (JIA)
Azathioprine or cyclophosphamide treatment within 6 months before entering into the study
Clareo Health | Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents
